US › Healthcare

Xtant Medical Holdings Inc (XTNT)

US · Healthcare · Medical Devices

$0.44-0.95%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$20.9M

Revenue YoY

-36.5%

Net profit

$-3.1M

Profit YoY

-5425.9%

EPS

$-0.02

EPS estimate

$-0.02

Net margin

-14.8%

EPS came in at -0.02 against a street estimate of -0.02 — a beat of 0.0%.

Key statistics

Market cap

$60.3M

P/E

43.0

Forward P/E

34.8

P/B

1.24

Book value

$0.35

EPS (TTM)

$0.01

52-week high

$0.95

52-week low

$0.39

50-day MA

$0.44

200-day MA

$0.59

Beta

-0.14

Analyst view

Analysts rate Xtant Medical Holdings Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $1.35.

Shareholding

Insiders

13.84%

Institutions

57.28%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Xtant Medical Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.